Literature DB >> 10549680

The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.

A L Miller1, J A Chiles, J K Chiles, M L Crismon, A J Rush, S P Shon.   

Abstract

BACKGROUND: In the Texas Medication Algorithm Project (TMAP), detailed guidelines for medication management of schizophrenia and related disorders, bipolar disorders, and major depressive disorders have been developed and implemented. DISCUSSION: This article describes the algorithms developed for medication treatment of schizophrenia and related disorders. The guidelines recommend a sequence of medications and discuss dosing, duration, and switch-over tactics. They also specify response criteria at each stage of the algorithm for both positive and negative symptoms. The rationale and evidence for each aspect of the algorithms are presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549680     DOI: 10.4088/jcp.v60n1002

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  27 in total

1.  Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment.

Authors:  Ian R H Falloon; Isabel Montero; Mehmet Sungur; Antonino Mastroeni; Ulf Malm; Marina Economou; Rolf Grawe; Judit Harangozo; Masafumi Mizuno; Masaaki Murakami; Bert Hager; Tilo Held; Franco Veltro; Robyn Gedye
Journal:  World Psychiatry       Date:  2004-06       Impact factor: 49.548

2.  Customizing treatment to the patient: adaptive treatment strategies.

Authors:  Susan A Murphy; L M Collins; A John Rush
Journal:  Drug Alcohol Depend       Date:  2007-03-09       Impact factor: 4.492

3.  [Computer-assisted treatment pathway for schizophrenia. Development and initial experiences].

Authors:  G Juckel; K Stahl; C Norra
Journal:  Nervenarzt       Date:  2015-01       Impact factor: 1.214

4.  Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.

Authors:  Natalie C Edwards; Julie C Locklear; Marcia F T Rupnow; Ronald J Diamond
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Improving psychotherapeutic medication prescribing in Florida: implementation of the Florida Medicaid Drug Therapy Management Program (MDTMP).

Authors:  Robert J Constantine; Marie A McPherson; Mary Elizabeth Jones; Rajiv Tandon; Edmund R Becker
Journal:  Community Ment Health J       Date:  2012-03-01

6.  Schizophrenia: overview and treatment options.

Authors:  Krishna R Patel; Jessica Cherian; Kunj Gohil; Dylan Atkinson
Journal:  P T       Date:  2014-09

7.  Recovery from schizophrenia: a four-year study of an inner city cohort.

Authors:  Marina Economou; Alexandra Palli; Lily Peppou; Michael Madianos
Journal:  Community Ment Health J       Date:  2011-02-22

Review 8.  Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective.

Authors:  Mauro Percudani; Corrado Barbui; Michele Tansella
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Concept and Management of Treatment Resistant Schizophrenia (TRS).

Authors:  Nitesh Painuly; Nitin Gupta; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2004-04       Impact factor: 1.759

10.  Implementing evidence-based practices for people with schizophrenia.

Authors:  Robert E Drake; Gary R Bond; Susan M Essock
Journal:  Schizophr Bull       Date:  2009-06-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.